Growth in global spending on medications will slow markedly over the next four years due to a slew of new low-cost generic drugs coming to pharmacies in the U.S. and other developed countries, along with slower increases in what those countries spend on brand-name drugs, according to a new forecast.
Related posts:
Fukushima Diary
Another asylum boat arrival
The US Has Become a Dystopian Novel: Is There a Drone in Your Backyard?
Brain tissue from former NFL star Seau to be studied for damage
London 2012 Olympics: Analysis says Team GB set for record breaking 57 medals
Chilling Statistics: What Are We Doing To Ourselves And Our Children?